Compare · MEDP vs ONMD
MEDP vs ONMD
Side-by-side comparison of Medpace Holdings Inc. (MEDP) and OneMedNet Corp (ONMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MEDP and ONMD operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- MEDP is the larger of the two at $15.36B, about 396.7x ONMD ($38.7M).
- Over the past year, MEDP is up 72.2% and ONMD is up 20.7% - MEDP leads by 51.6 points.
- ONMD has been more active in the news (7 items in the past 4 weeks vs 5 for MEDP).
- MEDP has more recent analyst coverage (25 ratings vs 0 for ONMD).
- Company
- Medpace Holdings Inc.
- OneMedNet Corp
- Price
- $537.63-0.04%
- $0.67-7.43%
- Market cap
- $15.36B
- $38.7M
- 1M return
- +16.40%
- +30.89%
- 1Y return
- +72.22%
- +20.65%
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2021
- News (4w)
- 5
- 7
- Recent ratings
- 25
- 0
Medpace Holdings Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Latest MEDP
- Medpace downgraded by Robert W. Baird with a new price target
- Medpace downgraded by Jefferies with a new price target
- Director Mccarthy Cornelius P. Iii converted options into 28 shares, increasing direct ownership by 0.27% to 10,352 units (SEC Form 4)
- Director Kraft Robert O. converted options into 33 shares, increasing direct ownership by 4% to 955 units (SEC Form 4)
- Director Carley Brian T converted options into 36 shares, increasing direct ownership by 0.11% to 32,825 units (SEC Form 4)
- Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026
- New insider Hansman Brad W. claimed ownership of 697 shares (SEC Form 3)
- SEC Form 8-K filed by Medpace Holdings Inc.
- General Counsel & Corp. Secy. Ewald Stephen P exercised 16,349 shares at a strike of $138.87 and sold $7,357,050 worth of shares (16,349 units at $450.00) (SEC Form 4)
- SEC Form 8-K filed by Medpace Holdings Inc.
Latest ONMD
- SEC Form 424B3 filed by OneMedNet Corp
- SEC Form EFFECT filed by OneMedNet Corp
- Amendment: SEC Form S-1/A filed by OneMedNet Corp
- SEC Form S-1 filed by OneMedNet Corp
- SEC Form 8-K filed by OneMedNet Corp
- Chief Executive Officer Green Aaron bought $21,011 worth of shares (36,650 units at $0.57), increasing direct ownership by 2% to 1,896,375 units (SEC Form 4)
- Chief Medical Officer Yu Jeffrey bought $100,000 worth of shares (158,730 units at $0.63), increasing direct ownership by 2% to 8,780,410 units (SEC Form 4)
- Chief Medical Officer Yu Jeffrey bought $100,000 worth of shares (172,414 units at $0.58), increasing direct ownership by 2% to 8,621,680 units (SEC Form 4)
- Chief Executive Officer Green Aaron bought $30,697 worth of shares (55,622 units at $0.55), increasing direct ownership by 3% to 1,859,725 units (SEC Form 4)
- Director Kosasa Thomas bought $100,000 worth of shares (158,730 units at $0.63), increasing direct ownership by 0.94% to 17,088,874 units (SEC Form 4)